These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 22772335)
1. Effect of dopamine D₃ receptor antagonism on approach responses to food cues in overweight and obese individuals. Mogg K; Bradley BP; O'Neill B; Bani M; Merlo-Pich E; Koch A; Bullmore ET; Nathan PJ Behav Pharmacol; 2012 Sep; 23(5-6):603-8. PubMed ID: 22772335 [TBL] [Abstract][Full Text] [Related]
2. The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects. Nathan PJ; O'Neill BV; Mogg K; Bradley BP; Beaver J; Bani M; Merlo-Pich E; Fletcher PC; Swirski B; Koch A; Dodds CM; Bullmore ET Int J Neuropsychopharmacol; 2012 Mar; 15(2):149-61. PubMed ID: 21745436 [TBL] [Abstract][Full Text] [Related]
3. Differences in attention to food and food intake between overweight/obese and normal-weight females under conditions of hunger and satiety. Nijs IM; Muris P; Euser AS; Franken IH Appetite; 2010 Apr; 54(2):243-54. PubMed ID: 19922752 [TBL] [Abstract][Full Text] [Related]
4. Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eaters. Dodds CM; O'Neill B; Beaver J; Makwana A; Bani M; Merlo-Pich E; Fletcher PC; Koch A; Bullmore ET; Nathan PJ Appetite; 2012 Aug; 59(1):27-33. PubMed ID: 22445776 [TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886 [TBL] [Abstract][Full Text] [Related]
15. Explicit memory bias for positively valenced body-related cues in women with binge eating disorder. Svaldi J; Bender C; Tuschen-Caffier B J Behav Ther Exp Psychiatry; 2010 Sep; 41(3):251-7. PubMed ID: 20199768 [TBL] [Abstract][Full Text] [Related]
16. Impairment of inhibitory control in response to food-associated cues and attentional bias of obese participants and normal-weight controls. Loeber S; Grosshans M; Korucuoglu O; Vollmert C; Vollstädt-Klein S; Schneider S; Wiers RW; Mann K; Kiefer F Int J Obes (Lond); 2012 Oct; 36(10):1334-9. PubMed ID: 21986703 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state. te Beek ET; Zoethout RW; Bani MS; Andorn A; Iavarone L; Klaassen ES; Fina P; van Gerven JM J Psychopharmacol; 2012 Feb; 26(2):303-14. PubMed ID: 22219221 [TBL] [Abstract][Full Text] [Related]
18. Sex differences in subjective and objective responses to a stimulant medication (methylphenidate): Comparisons between overweight/obese adults with and without binge-eating disorder. Davis C; Levitan RD; Kaplan AS; Carter-Major JC; Kennedy JL Int J Eat Disord; 2016 May; 49(5):473-81. PubMed ID: 26691428 [TBL] [Abstract][Full Text] [Related]
19. Gating of attention towards food stimuli in binge eating disorder. Schmitz F; Naumann E; Biehl S; Svaldi J Appetite; 2015 Dec; 95():368-74. PubMed ID: 26212270 [TBL] [Abstract][Full Text] [Related]
20. Top-down guidance of attention to food cues is enhanced in individuals with overweight/obesity and predicts change in weight at one-year follow up. Kaisari P; Kumar S; Hattersley J; Dourish CT; Rotshtein P; Higgs S Int J Obes (Lond); 2019 Sep; 43(9):1849-1858. PubMed ID: 30464229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]